Sources Novo Nordisk announces more than 400 million euro expansion in its manufacturing facility in Athlone, Ireland Novo Nordisk March 2, 2026 Novo Nordisk's Wegovy pill, the first and only oral GLP-1 for weight loss in adults, now broadly available across America Novo Nordisk January 5, 2026
According to FDA labeling, the precise mechanism for weight loss is not fully understood
without type 2 diabetes: HR, 1.19 [95% CI, 1.12-1.27])
speaker/consultation fees from Lundbeck, Janssen, Alkermes, Neumora Therapeutics, Boehringer Ingelheim, Sage, Biogen, Mitsubishi Tanabe, Purdue, Pfizer, Otsuka, Takeda, Neurocrine, Neurawell, Sunovion, Bausch Health, Axsome, Novo Nordisk, Kris, Sanofi, Eisai, Intra-Cellular, NewBridge Pharmaceuticals, Viatris, Abbvie and Atai Life Sciences